MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
China
The Second Xiangya Hospital of Central South University, Changsha, Hunan West China Hospital of Sichuan University, Chengdu, Sichuan Shanghai General Hospital, Shanghai Age range
18 Years and older
Last updated September 2025